Looking to sell Trialspark stock or options?Contact us
Trialspark is the creator of a biotech platform that revolutionizes drug development to expedite patient treatments. The company's platform has expanded a network of trial sites by transforming existing practices into clinical trial locations with a mobile team of certified research coordinators, all enhanced by state-of-the-art software, data, and technology. This allows researchers to broaden their access to human subjects for research studies, paid clinical trials, psychological research, and focus groups.
Sound Ventures, S32, Sam Altman, ArrowMark Partners, Michael Moritz, TQ Ventures, Mantis VC, Felicis, Cherubic Ventures, John Doerr, Thrive Capital, Lachy Groom, Emerson Collective, 3cubed Ventures, Casdin Capital, Spark Capital, AlphaLab.
We have an even better solution: The Collective Exchange Fund
Get in touch and see if we can help you